News | October 21, 2023
Evonik strengthens nanoparticle technologies and services portfolio for parenteral drug delivery
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Three-point improvement achieved in Sex Ratio at Birth from 904 in 2017-19 to 907 in 2018-20
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
_256_384.jpg)
GenWorks Health Introduces Braster Pro for breast screening & EVA for cervical screening in rural areas & communities
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
Animations, colors, and shapes help to improve poor situational awareness, which is responsible for 81.5% of anesthesia-related errors
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials
Subscribe To Our Newsletter & Stay Updated
